Silencing of miR490–3p by H. pylori activates DARPP-32 and induces resistance to gefitinib is a research paper published in Cancer Letters (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Research Career Scientist award
Grant: 1IK6BX003787
Research Career Scientist award
Grant: I01BX001179
U.S. National Institutes of Health
Grant: R01CA93999
Sylvester Comprehensive Cancer Center
Grant: P30CA240139
BLRD VA
Grant: IK6 BX003787
BLRD VA
Grant: I01 BX002115
NCI NIH HHS
Grant: R01 CA093999
NCI NIH HHS
Grant: R01 CA138833
BLRD VA
Grant: IK6 BX006300
NCI NIH HHS
Grant: R01 CA206564
National Institutes of Health
Grant: 2R01CA093999-07A2
Gene Amplification and Overexpression at 17q in Gastric Cancer: Darpp-32
National Institutes of Health
Grant: 3P30CA240139-02S3
The Sylvester Cancer Center Support Grant
National Institutes of Health
Grant: 2I01BX001179-09A1
Molecular Pathobiology of Gastric Carcinogenesis
National Institutes of Health
Grant: 5IK6BX003787-07
BLRD Research Career Scientist Award Application
U.S. Department of Veterans Affairs
FWCI
0.98
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals